PE20060976A1 - BENZOTIENO[2,3-d]PIRIMIDINAS COMO ANTAGONISTAS DEL RECEPTOR DEL FACTOR DE CRECIMIENTO (EGFRs) - Google Patents

BENZOTIENO[2,3-d]PIRIMIDINAS COMO ANTAGONISTAS DEL RECEPTOR DEL FACTOR DE CRECIMIENTO (EGFRs)

Info

Publication number
PE20060976A1
PE20060976A1 PE2005001212A PE2005001212A PE20060976A1 PE 20060976 A1 PE20060976 A1 PE 20060976A1 PE 2005001212 A PE2005001212 A PE 2005001212A PE 2005001212 A PE2005001212 A PE 2005001212A PE 20060976 A1 PE20060976 A1 PE 20060976A1
Authority
PE
Peru
Prior art keywords
halo
phenyl
benzothene
egfrs
antagonists
Prior art date
Application number
PE2005001212A
Other languages
English (en)
Inventor
Chengzhi Zhang
Roger Smith
Jason Duquette
Qian Zhao
Jacques Dumas
Georgiy Bondar
Yingfu Li
Dongping Fan
Original Assignee
Bayer Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharmaceuticals Corp filed Critical Bayer Pharmaceuticals Corp
Publication of PE20060976A1 publication Critical patent/PE20060976A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A UN BENZOTIENO DE FORMULA (I) DONDE m ES 0 A 2; R1 Y R2 SON H, ALQUILO, HALO; R3 ES -O(CH2)nAr DONDE Ar ES FENILO, TIENILO, FURILO, ENTRE OTROS; n es 0 O 1; R4 ES H, CH3, CH3CH2-, ENTRE OTROS; R5 ES H, CH3, HALO; R7 ES HALO, OH, IMIDAZOLILO, PIRROLIDINILO ENTRE OTROS; R8 ES HALO, CIANO, AMINO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: ETIL[4-({3-CLORO-4-[(3-FLUOROBENCIL)OXI]FENIL}AMINO)[1]BENZOTIEN[2,3-d]PIRIMIDIN-7-IL]ACETATO, 2-[4-({3-CLORO-4-[(3-FLUOROBENCIL)OXI]FENIL}AMINO)[1]BENZOTIENT[2,3-d]PIRIMIDIN-7-IL]ETANOL, 7-(2-BROMOETIL)-N-{3-CLORO-4-[(3-FLUOROBENCIL)OXI]FENIL}[1]BENZOTIEN[2,3-d]PIRIMIDIN-4-AMINA. TAMBIEN SE REFIERE A UN PROCEDIMIENTO DE PREPARACION. DICHOS COMPUESTOS SON ANTAGONISTAS DEL RECEPTOR DEL FACTOR DE CRECIMIENTO (EGFRs) SIENDO UTILES EN EL TRATAMIENTO DE ENFERMEDADES HIPERPROLIFERATIVAS COMO CANCER
PE2005001212A 2004-10-15 2005-10-14 BENZOTIENO[2,3-d]PIRIMIDINAS COMO ANTAGONISTAS DEL RECEPTOR DEL FACTOR DE CRECIMIENTO (EGFRs) PE20060976A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61906604P 2004-10-15 2004-10-15

Publications (1)

Publication Number Publication Date
PE20060976A1 true PE20060976A1 (es) 2006-10-20

Family

ID=35759133

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005001212A PE20060976A1 (es) 2004-10-15 2005-10-14 BENZOTIENO[2,3-d]PIRIMIDINAS COMO ANTAGONISTAS DEL RECEPTOR DEL FACTOR DE CRECIMIENTO (EGFRs)

Country Status (12)

Country Link
US (1) US7750017B2 (es)
EP (1) EP1802633B1 (es)
JP (1) JP5070058B2 (es)
AR (1) AR052019A1 (es)
AT (1) ATE518867T1 (es)
CA (1) CA2584303A1 (es)
ES (1) ES2369235T3 (es)
GT (1) GT200500291A (es)
PE (1) PE20060976A1 (es)
TW (1) TW200628473A (es)
UY (1) UY29161A1 (es)
WO (1) WO2006044524A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7982035B2 (en) 2007-08-27 2011-07-19 Duquesne University Of The Holy Spirit Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof
US7960400B2 (en) 2007-08-27 2011-06-14 Duquesne University Of The Holy Ghost Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof
WO2009104026A1 (en) * 2008-02-19 2009-08-27 Vichem Chemie Kutató Kft Tricyclic benzo[4,5]thieno-[2,3-d]pyrimidine-4-yl-amin derivatives, their salts, process for producing the compounds and their pharmaceutical use
RS53866B1 (en) 2008-07-16 2015-08-31 Richter Gedeon Nyrt. PHARMACEUTICAL FORMULATIONS CONTAINING DOPAMINE RECEPTOR LIGANDS
EP2872144A4 (en) * 2012-07-11 2015-12-02 Nimbus Iris Inc IRAQ INHIBITOR AND USES THEREOF
CN105189518A (zh) * 2013-02-01 2015-12-23 拜耳制药股份公司 取代的噻吩并吡啶和其药物用途
TW201605867A (zh) * 2013-11-20 2016-02-16 拜耳製藥公司 噻吩并嘧啶
HU231173B1 (hu) 2016-07-08 2021-06-28 Richter Gedeon Nyrt. Ipari eljárás cariprazine előállítására
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
CN111699176A (zh) 2017-12-21 2020-09-22 里邦医疗公司 作为parp14抑制剂的喹唑啉酮
CN108285421A (zh) * 2018-01-26 2018-07-17 黑龙江鑫创生物科技开发有限公司 一种微通道反应器合成拉帕替尼中间体的方法
CN108456184B (zh) * 2018-03-28 2020-02-07 南方医科大学 一种靶向egfr与eps8结合的小分子抑制剂及其应用
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder
CN110818618A (zh) * 2019-11-26 2020-02-21 山东铂源药业有限公司 一种吡咯替尼中间体2-[(2-氯-4-硝基苯氧基)甲基]吡啶的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654307A (en) * 1994-01-25 1997-08-05 Warner-Lambert Company Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
GB9520822D0 (en) 1995-10-11 1995-12-13 Wellcome Found Therapeutically active compounds
EP0892789B2 (en) * 1996-04-12 2009-11-18 Warner-Lambert Company LLC Irreversible inhibitors of tyrosine kinases

Also Published As

Publication number Publication date
UY29161A1 (es) 2006-04-28
AR052019A1 (es) 2007-02-28
EP1802633B1 (en) 2011-08-03
GT200500291A (es) 2006-10-10
CA2584303A1 (en) 2006-04-27
JP2008516963A (ja) 2008-05-22
WO2006044524A1 (en) 2006-04-27
ES2369235T3 (es) 2011-11-28
TW200628473A (en) 2006-08-16
JP5070058B2 (ja) 2012-11-07
US7750017B2 (en) 2010-07-06
EP1802633A1 (en) 2007-07-04
ATE518867T1 (de) 2011-08-15
US20080132497A1 (en) 2008-06-05

Similar Documents

Publication Publication Date Title
PE20060976A1 (es) BENZOTIENO[2,3-d]PIRIMIDINAS COMO ANTAGONISTAS DEL RECEPTOR DEL FACTOR DE CRECIMIENTO (EGFRs)
PE20091315A1 (es) Ciclopentanos de pirimidilo como inhibidores de la proteina cinasa akt
PE20060737A1 (es) 3-AMINO-PIRAZOL[3,4b] PIRIDINAS COMO INHIBIDORES DE PROTEINTIROSINQUINASAS Y SU PREPARACION
PE20080130A1 (es) Benzoimidazol-2-il pirimidinas y pirazinas como moduladores del receptor h4 de histamina
TW200608969A (en) Heterocyclic boronic acid compounds
PE20061060A1 (es) Derivados de taxanos como agentes citotoxicos
PE20090816A1 (es) Derivados de pirrolopirimidinona como agentes ligandos de los receptores p2x3
PE20121613A1 (es) Derivados de quinolina amida como moduladores alostericos positivos de receptores m1
PE20091376A1 (es) Derivados de fenilamino como moduladores de beta-amiloide
PE20080931A1 (es) Imidazopirazinas como inhibidores de proteina quinasa
PE20070218A1 (es) COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA
PE20120814A1 (es) Compuestos y composiciones como inhibidores de la proteina cinasa
PE20130152A1 (es) Derivados de heterociclo biciclicos como inhibidores de proteina quinasa b
PE20060215A1 (es) 4-fenilamino-quinazolin-6-il-amidas
PE20060383A1 (es) Nuevos derivados amino de urea ciclicos como inhibidores de quinasa
PE20030762A1 (es) Compuestos heterociclicos como antagonistas nk1
PE20080144A1 (es) Compuestos de tetrahidropiridotienopirimidina con actividad antiproliferativa
PE20040999A1 (es) Nuevas pirazolopirimidinas como inhibidores de cinasas dependientes de ciclinas
PE20061351A1 (es) COMPUESTOS 8H-PIRIDO[2,3-d]PIRIMIDIN-7-ONA 2,4,8-TRISUSTITUIDOS COMO INHIBIDORES DE LA QUINASA CSBP/RK/p38
PE20090370A1 (es) Derivados de heterociclo fusionado como inhibidores de quinasa
JP2008535902A5 (es)
RU2016129474A (ru) Изоксазолиновые композиции
UY28936A1 (es) Grupo de compuestos benzoil-amino-heterociclilo y composiciones farmaceuticas que los comprenden, utiles para tratamiento de enfermedades mediadas por glucoquinasa (gq)
PE20121180A1 (es) (heteroarilmetil) tiohidantoinas sustituidas como drogas anticancer
MX2011012337A (es) Nuevos derivados de pirimidina y su uso en el tratamiento de cancer y de otras enfermedades.

Legal Events

Date Code Title Description
FC Refusal